[go: up one dir, main page]

HK1230963A1 - Novel methods for treating cancer - Google Patents

Novel methods for treating cancer Download PDF

Info

Publication number
HK1230963A1
HK1230963A1 HK17104737.1A HK17104737A HK1230963A1 HK 1230963 A1 HK1230963 A1 HK 1230963A1 HK 17104737 A HK17104737 A HK 17104737A HK 1230963 A1 HK1230963 A1 HK 1230963A1
Authority
HK
Hong Kong
Prior art keywords
treating cancer
novel methods
kinases
methods
cscpk
Prior art date
Application number
HK17104737.1A
Other languages
Chinese (zh)
Inventor
Chiang J. Cambridge LI
Youzhi Westwood LI
Original Assignee
Boston Biomedical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Biomedical, Inc. filed Critical Boston Biomedical, Inc.
Publication of HK1230963A1 publication Critical patent/HK1230963A1/en

Links

Abstract

The invention provides thiazole-substituted indolin-2-ones as inhibitors of cancer stem cell pathway kinases (CSCPK) and related kinases, and methods of using these compounds, to treat subjects in need thereof.
HK17104737.1A 2014-01-27 2015-01-26 Novel methods for treating cancer HK1230963A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61/932,186 2014-01-27
US61/938,391 2014-02-11

Publications (1)

Publication Number Publication Date
HK1230963A1 true HK1230963A1 (en) 2017-12-15

Family

ID=

Similar Documents

Publication Publication Date Title
PH12017501155B1 (en) Thieno [2,3-c] pyrrol-4-one derivatives as erk inhibitors
MX2019001125A (en) Macrocycle kinase inhibitors.
LT3472153T (en) PYRIMIDIN-2-ILAMINO-1H-PYRASOLS AS LRRK2 INHIBITORS FOR USE IN THE TREATMENT OF NEURODEGGENIC DISORDERS
NZ731467A (en) Anti-tim3 antibodies and methods of use
WO2014164704A3 (en) Compounds and compositions for the treatment of cancer
IL253979A0 (en) Methods, compositions, and kits for treatment of cancer
PH12016500330B1 (en) Certain chemical entities, compositions, and methods
HK1220980A1 (en) Methods and compositions for treatment of pompe disease
MX2015011898A (en) Pyrazolo compounds and uses thereof.
PH12016502099A1 (en) 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds which are jak inhibitors
NZ724691A (en) Quinoline derivatives as smo inhibitors
MX2018006632A (en) Bicyclic inhibitors of pad4.
HK1243935A1 (en) Organic compounds
MX373129B (en) INDOLIZINE DERIVATIVES AS PHOSPHOINOSITIDE-3 KINASE INHIBITORS.
MX2018006700A (en) Aza-benzimidazole inhibitors of pad4.
WO2014205266A3 (en) Compositions and methods for detecting and treating glioblastoma
MX2016014436A (en) Heterocyclyl-butanamide derivatives.
HK1258276A1 (en) Compounds and combinations for the treatment of hiv
MX382092B (en) Heterocyclic compounds for the treatment of disease
HK1254231A1 (en) Mito-honokiol compounds and methods of synthesis and use thereof
HK1243936A1 (en) Organic compounds
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
HK1255053A1 (en) Compositions and methods for inhibiting cancer stem cells
EP3302487A4 (en) Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions, and methods for producing same
WO2016046759A3 (en) Compositions and methods for treating friedreich's ataxia